Skip to main content
. 2022 Mar 29;2022(3):CD010893. doi: 10.1002/14651858.CD010893.pub4

Comparison 3. ImmunoGuard versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
3.1 Acute‐phase response 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
3.1.1 ESR (mm/hour) 1 23 Mean Difference (IV, Fixed, 95% CI) ‐2.90 [‐10.86, 5.06]
3.1.2 WBC count (109/L) 1 23 Mean Difference (IV, Fixed, 95% CI) ‐0.90 [‐4.66, 2.86]
3.1.3 CRP (mg/L) 1 23 Mean Difference (IV, Fixed, 95% CI) ‐0.36 [‐1.29, 0.57]